While the majority order by four members concluded that there was no evidence of competition norms violations by the entity, one CCI member decided to impose penalty.
The majority ruling has come after a detailed probe by CCI's investigation arm Director General (DG), which had concluded that there are competition norm violations.
The complaint was filed by medicines distributor Royal Agency against the Chemists and Druggists Association, Goa (Opposite Party 1) and Franco-Indian Pharmaceuticals (OP 2).
The Commission finds that based on the evidence and material available on record, no contravention of the provisions of section 3 of Competition Act by the opposite parties has been established, as per majority order by four members - S L Bunker, Sudhir Mital, U C Nahta and M S Sahoo.
Section 3 pertains to anti-competitive agreements.
Citing available information, Competition Commission of India (CCI) said Drogaria Menezes and Cia's proprietor Agostinho Menezes has been an authorised distributor of OP 2 and Royal Agency's Maria proprietor Rodrigues worked with him for about 30 years before leaving in April 2013.
The majority order noted that even though the DG has concluded that OP 1 has played an active role in discontinuation of supplies to the informant, the same is not supported by sufficient evidence.
In his dissenting order, CCI member Augustine Peter has imposed a total penalty of Rs 1.26 crore on five entities -- the association, Franco Indian Pharma, Drogaria Menezes and Cia, Agostinho Menezes and Ramesh Chaturvedi, distribution manager at Franco Indian.
Also, Agosthino Menezes in his dual capacity as proprietor of Drogaria Menezes and Cia and as the wholesalers chairman of the association has been responsible for entering into an agreement with Franco Indian Pharmaceuticals for distributorship and further influencing OP 2 to stop supply of products to the informant, it added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
